Light-induced analgesia provides a drug-free optical method for pain relief via activation of TRAAK k+ channels

Read full text
Authors: Marion Bied, Arnaud Landra-Willm, Anne Amandine Chassot, Edward Francisco Mendez-Otalvaro, Benjamin Sueur, Kilian Roßmann, Elvira de la Peña, Pascal Fossat, Stephen J. Tucker, Jacques Noël, Wojciech Kopeć, Félix Viana
+3 more Johannes Broichhagen, Éric Boué‐Grabot, Guillaume Sandoz
Cited by: 6
References: 72

Abstract

Pain management in animal experimentation is crucial for both ethical and scientific reasons, as unmanaged pain can distort physiological responses compromising data reliability. Current strategies are often invasive and pharmacology-based, introducing variability and confounding effects. Here, we present Light-Induced Analgesia, a drug-free, non-invasive method for pain relief in animals. We show that 365 nm illumination activates the pain-inhibitory TRAAK two-pore domain potassium (K2P) channel. This activation is driven by the oxidation of a native methionine at TRAAK's regulatory fenestration site, triggering a conformational switch from its inactive (down) to active (up) state. We further demonstrate that this mechanism can be transferred to other related K2Ps via a single-point mutation, rendering them light-sensitive. In rodents, gentle skin exposure to 365 nm is sufficient to activate endogenous TRAAK, silence nociceptors, and produce potent, long-lasting analgesia that outperforms standard treatments. Light-Induced Analgesia thus offers an effective, drug-free alternative that can enhance animal welfare and experimental reliability in preclinical research.

Fields of Study & Subjects

Photoreceptor and optogenetics research Photochromic and Fluorescence Chemistry Neuroscience and Neuropharmacology Research

Publication details

Journal / source
Nature Communications
Publisher
Springer Science and Business Media LLC
Volume
17
Issue
1
Pages
620–620
Publication date
26 January 2026
Language
EN